<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR36">
 <label>36.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Conibear</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Chia</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Ngai</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Bates</surname>
    <given-names>AT</given-names>
   </name>
   <name>
    <surname>Counsell</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Patel</surname>
    <given-names>R</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer</article-title>
  <source>BMJ Open</source>
  <year>2018</year>
  <volume>8</volume>
  <issue>4</issue>
  <fpage>e020690</fpage>
  <pub-id pub-id-type="doi">10.1136/bmjopen-2017-020690</pub-id>
 </element-citation>
</ref>
